Department of Bio and Brain Engineering, KAIST, Republic of Korea.
Microvasc Res. 2010 Dec;80(3):310-6. doi: 10.1016/j.mvr.2010.05.006. Epub 2010 May 25.
We examined the protective effect of unsorted human adipose tissue-derived stem cells (hADSCs) with a short-term culture in endothelial differentiation medium on tissue repair after ischemic injury. hADSCs were isolated from human subcutaneous adipose tissue and cultured in vitro in endothelial differentiation medium for 2wks before transplantation. Cultured hADSCs showed a typical mesenchymal stromal cell-like phenotype, positive for endothelial-specific markers including VE-cadherin, Flt-1, eNOS, and vWF but not CD31. Two hours after ligation of the femoral artery and vein, mice were injected with the unselected hADSCs locally near the surgery site and tested for tissue perfusion and repair. Tissue perfusion rates of the ischemic limbs were significantly higher in the group treated with hADSCs compared with those of the control mice as early as post-operative day 3 (median 195.3%/min; interquartile range, 82.0-321.1 vs. median 47.1%/min; interquartile range, 18.0-58.7; p=0.001 by Friedman two-way analysis). Subsequently, the mice treated with hADSC showed better prognosis at 4wks after surgery, and the histological analysis revealed increased vascular density and reduced muscle atrophy in the hADSC-transplanted limbs. Moreover, hADSC-treated muscle contained differentiated myocytes positive for human NF-κB and myogenin antigen. These results collectively indicate that unsorted hADSCs after a 2-wk-in vitro culture have a therapeutic potential in ischemic tissue injury via inducing both angiogenesis and myogenesis.
我们研究了短期培养于内皮细胞分化培养基中的未分选的人脂肪组织来源的干细胞(hADSCs)对缺血性损伤后组织修复的保护作用。hADSCs 从人皮下脂肪组织中分离出来,在体外于内皮细胞分化培养基中培养 2 周后进行移植。培养的 hADSCs 表现出典型的间充质基质细胞样表型,内皮特异性标志物阳性,包括 VE-cadherin、Flt-1、eNOS 和 vWF,但 CD31 阴性。在股动静脉结扎后 2 小时,将未分选的 hADSCs 局部注射到手术部位附近,并检测组织灌注和修复情况。与对照组相比,hADSCs 治疗组缺血肢体的组织灌注率在术后第 3 天(中位数 195.3%/min;四分位距,82.0-321.1 与中位数 47.1%/min;四分位距,18.0-58.7;p=0.001,采用 Friedman 双向分析)就显著升高。随后,hADSC 治疗组在术后 4 周时的预后更好,组织学分析显示,hADSC 移植肢体的血管密度增加,肌肉萎缩减少。此外,hADSC 治疗的肌肉中含有分化的肌细胞,对人 NF-κB 和肌生成素抗原呈阳性。这些结果共同表明,在体外培养 2 周后的未分选的 hADSCs 通过诱导血管生成和肌生成,具有治疗缺血性组织损伤的潜力。